tert-Butyl 4-(6-Nitropyridin-3-yl)piperazine-1-Carboxylate CAS 571189-16-7 Ucoceko >98.0% (HPLC) Palbociclib Intermediate Factory
I-Ruifu Chemical Supply Palbociclib Related Intermediates:
Palbociclib CAS 571190-30-2
5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5
I-5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine CAS 733039-20-8
tert-Butyl 4-(6-Nitropyridin-3-yl)piperazine-1-Carboxylate CAS 571189-16-7
tert-Butyl 4-(6-Amino-3-Pyridyl)piperazine-1-Carboxylate CAS 571188-59-5
6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pyrimidin-7 (8H)-enye CAS 1016636-76-2
I-2-Chloro-8-Cyclopentyl-5-Methyl-8H-Pyrido[2,3-d]pyrimidin-7-enye CAS 1013916-37-4
Igama leMchiza | tert-Butyl 4-(6-Nitropyridin-3-yl)piperazine-1-Carboxylate |
Izithethantonye | 1-Boc-4-(6-Nitro-3-Pyridyl)piperazine;I-4-(6-Nitro-3-pyridinyl) -1-Piperazinecarboxylic Acid tert-Butyl Ester;tert-Butyl 4-(6-Nitro-3-Pyridinyl)-1-Piperazinecarboxylate |
Inombolo yeCAS | 571189-16-7 |
Inombolo yeCAT | RF-PI1850 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | I-C14H20N4O4 |
Ubunzima beMolekyuli | 308.33 |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | I-Brown eKhanya ukuya kwi-Brown Powder |
Ubunyulu / Indlela yokuHlalutya | >98.0% (HPLC) |
I-LCMS | Ukungqinelana Nolwakhiwo |
Ilahleko ekomisweni | <1.00% |
Ukungcola ngokupheleleyo | <2.00% |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | Umbindi wePalbociclib (CAS: 571190-30-2) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma
tert-Butyl 4-(6-nitropyridin-3-yl)piperazine-1-carboxylate (CAS: 571189-16-7) iphakathi kwePalbociclib (CAS: 571190-30-2).I-Palbociclib (ekwaziwa ngokuba yi-compound number PD-0332991) lichiza lovavanyo lonyango lomhlaza wamabele eliphuhliswa yiPfizer.Yi-inhibitor ekhethiweyo ye-cyclin-dependent kinases CDK4 kunye ne-CDK6.I-Palbociclib ivimba ukuqhubela phambili komjikelo weseli ukusuka kwisigaba se-G1 ukuya kwi-S ngokuthintela i-CDK4/6-exhomekeke kwi-retinoblastoma (RB) phosphorylation.I-Palbociclibhas isetyenziselwe unyango lwe-HER2 negative, i-estrogen receptor (ER) yomhlaza webele we-metastatic.